From BioBridge Training 2 to the 2026 London Symposium
Following BioBridge Training 2 London on 4–5 June 2026, the next step in the UK educational pathway is becoming clearer. What began in London as a two-day programme combining a scientific forum and advanced hands-on training should now be understood as part of a broader effort to support sound, structured and reproducible medical training in regenerative medicine.
The June programme was designed for healthcare professionals and built around a progression from science to workflow. Public event material describes a structure centred on PRP physiology, HA+PRP microenvironment logic, fibrin / ATS rationale and device compliance, while the practical training translated those principles into specialty-specific reasoning across andrology, women’s health and dermal practice.
In content terms, the London pathway already reflects the main Regen Lab product families used in professional education.
RegenPRP™ supports the narrative around standardised leucocyte-reduced PRP and reproducible preparation. RegenPRP™ – HA / Cellular Matrix supports the logic of a cell-friendly HA-PRP network and a hydration-to-support continuum. RegenPRP™ + ATS supports the fibrin-based scaffold and structural logic that underpins gel and biofiller-style educational discussion.
This is also why the London educational pathway matters for the UK context. The direction is not generic promotion. It is the development of evidence-aware and governance-led education around biological rationale, workflow discipline, documentation, patient communication and safe implementation in clinic.
RegenPRP™
Standardised leucocyte-reduced platelet concentrate; user-independent standardised preparation; safe closed-circuit system.
RegenPRP™ - HA / Cellular Matrix
Closed-circuit preparation of a cell-friendly PRP-HA network; HA presented by Regen Lab as supporting matrix logic and hydration.
RegenPRP™ + ATS
Physiological coagulation activation and fibrin-matrix formation for longer-lasting growth factor delivery and scaffold support.
The next milestone is the BioBridge International Symposium planned for 18 September 2026 at the Royal Society of Medicine. Within that progression, the June London programme should now be read as the practical educational prelude, and the September symposium as the broader scientific and educational forum.
Reference Links
BioBridge Training 2 London
***
BioBridge Knowledge Platform
***
BioBridge Foundation LinkedIn
***
UK 2026 Clinicians’ Webinar Series
***